NQO1 and cancer: In this regard, deoxynyboquinone (DNQ) and isobutyl–deoxynyboquinone (IB-DNQ) are NQO1 bioactivatable substrates that cause the production of large amounts of ROS that cannot be tolerated by the cancer cells, leading to their death [19, 27, 30].